Researchers presented a nanotechnology platform based on natural lipoproteins, designed for delivering small interfering RNA, antisense oligonucleotides, and messenger RNA to myeloid cells and hematopoietic stem and progenitor cells in the bone marrow.
[Nature Nanotechnology]